Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Studies of NRP-104 pharmacokinetics, abuse potential reported

June 29, 2006

Preliminary results from phase II studies of cocaine vaccine TA-CD

June 28, 2006

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

June 27, 2006

Novel human anticocaine monoclonal antibody limits cocaine distribution to the brain

June 26, 2006

bPiDDB blocks nicotine-induced dopamine release in the nucleus accumbens

June 26, 2006

NDA submission for Cyanokit for cyanide poisoning

June 23, 2006

Novel dopamine D3 receptor antagonists for drug dependence emerge from Bioprojet R&D

June 21, 2006

Vivitrol for alcohol dependence now available

June 15, 2006

Japanese NHI price listing for Nicotinell TTS

June 2, 2006

Proof-of-concept study for NicVAX in smoking cessation

May 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.